FDA NDC Directory · JSON-LD · Markdown
NDC 25021-052 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION
| Labeler / Manufacturer | Sagent Pharmaceuticals |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA215654 |
| Dosage form / route | INJECTION, SOLUTION · INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE |
| Active ingredients | DEXAMETHASONE SODIUM PHOSPHATE (4 mg/mL) |
| Marketing started | 20241201 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).